In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas

40Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In vitro activities of omadacycline, a new aminomethylcycline, were determined for Mycoplasma and Ureaplasma spp. and compared with those of azithromycin, clindamycin, moxifloxacin, tetracycline, and doxycycline. All omadacycline MICs were <2 μg/ml. MIC90s were 0.063 μg/ml for Mycoplasma hominis, 0.25 μg/ml for Mycoplasma pneumoniae, and 2 μg/ml for Ureaplasma spp. Omadacycline had the lowest MIC90 among all drugs tested against M. hominis. Omadacycline activity was not affected by macrolide, tetracycline, or fluoroquinolone resistance.

Cite

CITATION STYLE

APA

Waites, K. B., Crabb, D. M., Liu, Y., & Duffy, L. B. (2016). In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrobial Agents and Chemotherapy, 60(12), 7502–7504. https://doi.org/10.1128/AAC.01734-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free